1.96
Immix Biopharma Inc stock is traded at $1.96, with a volume of 432.31K.
It is down -7.55% in the last 24 hours and down -27.68% over the past month.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
See More
Previous Close:
$2.12
Open:
$2.12
24h Volume:
432.31K
Relative Volume:
1.70
Market Cap:
$56.51M
Revenue:
-
Net Income/Loss:
$-14.14M
P/E Ratio:
-2.1304
EPS:
-0.92
Net Cash Flow:
$-12.64M
1W Performance:
-10.50%
1M Performance:
-27.68%
6M Performance:
+24.05%
1Y Performance:
-10.09%
Immix Biopharma Inc Stock (IMMX) Company Profile
Name
Immix Biopharma Inc
Sector
Industry
Phone
(888) 958-1084
Address
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
IMMX
Immix Biopharma Inc
|
1.96 | 61.13M | 0 | -14.14M | -12.64M | -0.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Immix Biopharma Inc Stock (IMMX) Latest News
How to build a custom watchlist for Immix Biopharma Inc.Quarterly Profit Report & Fast Entry Momentum Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Immix Biopharma Inc.Weekly Stock Recap & High Return Stock Watch Alerts - Newser
Is now a turning point for Immix Biopharma Inc.July 2025 Final Week & Pattern Based Trade Signal System - Newser
What high frequency data says about Immix Biopharma Inc.July 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Analyzing Immix Biopharma Inc. with risk reward ratio chartsWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser
Quantitative breakdown of Immix Biopharma Inc. recent movePortfolio Profit Report & Weekly Hot Stock Watchlists - Newser
What to expect from Immix Biopharma Inc. in the next 30 daysDay Trade & Free Risk Controlled Daily Trade Plans - Newser
Sector ETF performance correlation with Immix Biopharma Inc.Earnings Performance Report & Weekly Momentum Stock Picks - Newser
Predicting Immix Biopharma Inc. trend using moving averagesPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser
Long term hold vs stop loss in Immix Biopharma Inc.Portfolio Profit Report & Long-Term Growth Plans - Newser
Ranking Immix Biopharma Inc. among high performing stocks via toolsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
Developing predictive dashboards with Immix Biopharma Inc. data2025 Bull vs Bear & Stock Market Timing Techniques - Newser
Market reaction to Immix Biopharma Inc.’s recent news2025 Year in Review & High Accuracy Trade Alerts - Newser
Is Immix Biopharma Inc. building a consolidation baseTrade Exit Report & Low Drawdown Trading Strategies - Newser
Immix Biopharma : Presentation (IMMX Corporate presentation August 2025 1) - MarketScreener
Will Immix Biopharma Inc. outperform the marketTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
Immix Biopharma Inc. stock prediction for this weekMarket Growth Report & Technical Analysis for Trade Confirmation - Newser
Using data models to predict Immix Biopharma Inc. stock movementJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
Key metrics from Immix Biopharma Inc.’s quarterly dataWeekly Investment Report & Entry Point Confirmation Signals - Newser
Sentiment analysis tools applied to Immix Biopharma Inc.July 2025 Intraday Action & Community Trade Idea Sharing - Newser
Immix Biopharma to Present at the Stifel 2025 Healthcare Conference - GlobeNewswire
Clinical-Stage Biotech ImmixBio to Showcase Cell Therapy Pipeline at Major Stifel Healthcare Conference - Stock Titan
Is Immix Biopharma Inc. trending in predictive chart modelsTrade Volume Report & Capital Protection Trade Alerts - Newser
Bullish Divergence Spotted in Immix Biopharma Inc. MomentumJuly 2025 Sentiment & Reliable Volume Spike Trade Alerts - newsyoung.net
Is Immix Biopharma Inc. likely to announce a buyback2025 AllTime Highs & Fast Exit Strategy with Risk Control - sisain.net
Moving Averages: What are Immix Biopharma Inc.’s technical support levels2025 Fundamental Recap & Safe Entry Point Identification - sundaytimes.kr
Immix Biopharma Inc. stock daily chart insightsJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
Can Immix Biopharma Inc. stock outperform in a bear marketJuly 2025 Earnings & Free Community Supported Trade Ideas - theviewers.co.kr
Immix Biopharma Inc. Rebound Backed by Sentiment ShiftEarnings Recap Summary & Reliable Intraday Trade Alerts - newsyoung.net
Can Immix Biopharma Inc. grow without external fundingJuly 2025 Spike Watch & Weekly Hot Stock Watchlists - 더경남뉴스
Can Traders Expect Breakout From Immix Biopharma Inc. This WeekJuly 2025 Short Interest & Weekly Setup with ROI Potential - beatles.ru
Should you wait for a breakout in Immix Biopharma Inc.July 2025 Short Interest & AI Optimized Trade Strategies - Newser
Immix Biopharma Inc Stock (IMMX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):